We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Elanco Animal Health Incorporated (ELAN) Stock Jumps 11.7%: Will It Continue to Soar?
Read MoreHide Full Article
Elanco Animal Health Incorporated (ELAN - Free Report) shares ended the last trading session 11.7% higher at $11.84. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.8% gain over the past four weeks.
Elanco Animal Health Incorporated recorded a strong price increase after the company and the U. S. Environmental Protection Agency (EPA) announced that EPA, with the FDA’s support, had completed its comprehensive, multi-year review of the Seresto flea and tick collar. EPA confirmed continued registration of the collar, while comprehensive data affirmed the safety profile of Seresto.
This company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of -86.1%. Revenues are expected to be $1.04 billion, down 11.9% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Elanco Animal Health Incorporated, the consensus EPS estimate for the quarter has been revised 2.5% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ELAN going forward to see if this recent jump can turn into more strength down the road.
Elanco Animal Health Incorporated is part of the Zacks Medical - Outpatient and Home Healthcare industry. Aveanna Healthcare (AVAH - Free Report) , another stock in the same industry, closed the last trading session 4.9% lower at $1.56. AVAH has returned 10.1% in the past month.
For Aveanna, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.04. This represents a change of -233.3% from what the company reported a year ago. Aveanna currently has a Zacks Rank of #3 (Hold).
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Elanco Animal Health Incorporated (ELAN) Stock Jumps 11.7%: Will It Continue to Soar?
Elanco Animal Health Incorporated (ELAN - Free Report) shares ended the last trading session 11.7% higher at $11.84. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 3.8% gain over the past four weeks.
Elanco Animal Health Incorporated recorded a strong price increase after the company and the U. S. Environmental Protection Agency (EPA) announced that EPA, with the FDA’s support, had completed its comprehensive, multi-year review of the Seresto flea and tick collar. EPA confirmed continued registration of the collar, while comprehensive data affirmed the safety profile of Seresto.
This company is expected to post quarterly earnings of $0.05 per share in its upcoming report, which represents a year-over-year change of -86.1%. Revenues are expected to be $1.04 billion, down 11.9% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Elanco Animal Health Incorporated, the consensus EPS estimate for the quarter has been revised 2.5% lower over the last 30 days to the current level. And a negative trend in earnings estimate revisions doesn't usually translate into price appreciation. So, make sure to keep an eye on ELAN going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Elanco Animal Health Incorporated is part of the Zacks Medical - Outpatient and Home Healthcare industry. Aveanna Healthcare (AVAH - Free Report) , another stock in the same industry, closed the last trading session 4.9% lower at $1.56. AVAH has returned 10.1% in the past month.
For Aveanna, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at -$0.04. This represents a change of -233.3% from what the company reported a year ago. Aveanna currently has a Zacks Rank of #3 (Hold).